BOIRON SA INH. EO 1
stock DE:BON (FRANKFURT)

Alternative ID: FR0000061129

Need an investment idea? Check out S2O Stock Screener. It allows to generate a list of stocks of a particular interest in a matter of seconds!

Exchange: FRANKFURT
Sector: Health Care
Industry: Drug Manufacturers—Specialty & Generic
Market Cap: Small (798.67M)
Data in EUR

EPS: 1.50
Current PE: 0.84
BVPS: 27.94
Price/BVPS: 0.06
Dividend: 0.95 / 2.1%

Hist Grade: F (0.00)
YOY Grade: F (13.62)
Debt/FCF: 1.16
ROIC: 21.5%
PEG: 0.05
PEGY: 0.05

Value Price: 21.21
MOS Price: 10.61
MOS %: 1,277.3%
Graham Number: 30.68
Graham MOS %: 1,892.0%
IRT: 0.00

Market Price

1.54

0.06 4.1%

as of Mar 30 '23

52 Week Range:

0.95 49.15

Stock Analyzer Tutorials

General Info

type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

Financial Statements

type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

Growth Grade and Financial Ratios

type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

Price Charts

type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

Exchange: FRANKFURT
Sector: Health Care
Industry: Drug Manufacturers—Specialty & Generic
Market Cap: Small (798.67M)
Inst. Ownership: 9.26%
Insider Ownership: 75.48%
Full Time Employees: 2794

Boiron SA manufactures and sells homeopathic medicines in France, rest of Europe, North America, and internationally. The company offers non-proprietary, proprietary, branded homeopathic medicines. Its branded homeopathic medicines include Oscillococcinum to treat influenza symptoms, such as fever, chills, headaches, and aches; Stodal and Stodaline for treating coughs; Arnigel for adjunctive local treatment of benign trauma in the absence of open wounds; Camilia for the treatment of teething problems for babies; and Sédatif PC to treat anxiety and emotional, and minor sleep disorders. The company's homeopathic medicines also comprise Coryzalia for the treatment of cold symptoms and rhinitis; Homéoptic to treat eye discomfort and irritation due to various causes for adults and children; and Homéovox for vocal disorders. In addition, it provides dietary supplement; Dermoplasmine stick, baume, and mousse to treat dry lips and skin; Mag' Nuit, a formula to fall asleep; Arnitrosium for joint pain; Castor Equi Boiron ointment for treatment of cracked skin; and Storinyl, a syrup to treat colds. Further, it offers herbal medicines, such as Canephron to increase the amount of urine and to improve urinary elimination; moisturizing baby milk; and medical devices, including a range of COVID self-tests and rapid antigenic tests. The company offers its products through distribution centers, pharmacies, pharmacy chains, wholesalers, grocery and drugstores, health food stores, and online retail. Boiron SA was founded in 1932 and is headquartered in Messimy, France.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement

Cash Flow Statement

Balance Sheet

Liquidity Ratios

Current Ratio

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Equity (BVPS)	15.30	18.78	17.10	20.56	19.73	22.45	25.04	25.72	25.97	27.52	27.94
growth rate		22.8%	-9.0%	20.2%	-4.0%	13.8%	11.5%	2.7%	1.0%	6.0%	1.5%
Earnings BIT	67.46	82.34	146.03	146.11	135.18	133.92	130.01	108.40	83.79	81.86	48.96
growth rate		22.1%	77.4%	0.1%	-7.5%	-0.9%	-2.9%	-16.6%	-22.7%	-2.3%	-40.2%
Avg.PE	10.07	11.07	12.02	4.27	4.27	19.23	17.24	12.63	16.85	16.85	16.85
growth rate		9.9%	8.6%	-64.5%	0.0%	350.4%	-10.4%	-26.7%	33.4%	0.0%	0.0%
ROA	7.38	8.51	13.22	13.32	10.83	10.72	10.06	7.33	5.31	3.39	3.68
growth rate		15.3%	55.4%	0.8%	-18.7%	-1.0%	-6.2%	-27.1%	-27.6%	-36.2%	8.6%
ROE	11.87	13.74	22.10	23.09	18.58	17.56	15.86	11.45	8.20	5.17	5.49
growth rate		15.8%	60.8%	4.5%	-19.5%	-5.5%	-9.7%	-27.8%	-28.4%	-37.0%	6.2%
ROIC	11.51	13.43	21.73	22.61	18.13	17.23	15.46	11.16	8.00	5.02	5.33
growth rate		16.7%	61.8%	4.1%	-19.8%	-5.0%	-10.3%	-27.8%	-28.3%	-37.3%	6.2%
Cur. Ratio	1.81	1.82	2.13	2.23	2.47	2.77	2.92	2.54	3.00	2.50	2.86
growth rate		0.6%	17.0%	4.7%	10.8%	12.2%	5.4%	-13.0%	18.1%	-16.7%	14.4%
Quick Ratio	1.27	1.37	1.71	1.78	1.96	2.25	2.41	1.97	2.29	1.88	2.21
growth rate		7.9%	24.8%	4.1%	10.1%	14.8%	7.1%	-18.3%	16.2%	-17.9%	17.6%
Leverage	1.59	1.64	1.70	1.76	1.67	1.61	1.55	1.58	1.51	1.54	1.45
growth rate		3.1%	3.7%	3.5%	-5.1%	-3.6%	-3.7%	1.9%	-4.4%	2.0%	-5.8%
Balance Sheet	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Acct.Receivable	95.74	119.00	134.37	132.23	122.50	125.03	124.74	126.15	128.54	116.44	126.31
growth rate		24.3%	12.9%	-1.6%	-7.4%	2.1%	-0.2%	1.1%	1.9%	-9.4%	8.5%
Acct.Payable		41.00	39.01	38.28	38.56	39.07	43.27	58.87	41.43	38.20	44.18
growth rate			-4.9%	-1.9%	0.7%	1.3%	10.7%	36.1%	-29.6%	-7.8%	15.7%
Cur.Assets	267.91	273.00	352.00	349.87	381.38	432.23	465.17	419.75	414.39	441.46	452.36
growth rate		1.9%	28.9%	-0.6%	9.0%	13.3%	7.6%	-9.8%	-1.3%	6.5%	2.5%
Total Assets	479.40	594.00	667.59	669.55	695.45	755.03	800.40	767.08	764.28	781.82	770.70
growth rate		23.9%	12.4%	0.3%	3.9%	8.6%	6.0%	-4.2%	-0.4%	2.3%	-1.4%
Cash	85.20	97.00	160.95	161.03	195.41	244.31	275.01	217.25	208.44	234.69	234.50
growth rate		13.9%	65.9%	0.1%	21.4%	25.0%	12.6%	-21.0%	-4.1%	12.6%	-0.1%
Inventory	57.24	54.00	52.88	52.73	59.72	59.10	60.90	70.75	72.25	85.04	85.56
growth rate		-5.7%	-2.1%	-0.3%	13.3%	-1.1%	3.1%	16.2%	2.1%	17.7%	0.6%
Cur.Liabilities	147.62	150.00	165.19	156.96	154.62	156.15	159.17	165.29	138.25	176.55	158.24
growth rate		1.6%	10.1%	-5.0%	-1.5%	1.0%	1.9%	3.9%	-16.4%	27.7%	-10.4%
Liabilities	148.10	267.00	275.73	289.67	279.40	285.44	282.91	281.03	258.82	272.65	238.93
growth rate		80.3%	3.3%	5.1%	-3.5%	2.2%	-0.9%	-0.7%	-7.9%	5.3%	-12.4%
LT Debt	0.00	3.00	3.41	4.20	4.68	5.06	4.79	4.21	4.54	3.29	2.35
growth rate			13.6%	23.3%	11.4%	8.1%	-5.2%	-12.3%	7.9%	-27.4%	-28.7%
Equity	331.30	326.40	391.70	379.73	415.95	469.52	517.46	486.00	505.48	509.14	531.74
growth rate		-1.5%	20.0%	-3.1%	9.5%	12.9%	10.2%	-6.1%	4.0%	0.7%	4.4%
Common Shares	21.00	21.00	19.00	19.00	18.00	18.00	18.00	17.57	17.55	17.55	17.55
growth rate		0.0%	-9.5%	0.0%	-5.3%	0.0%	0.0%	-2.4%	-0.1%	0.0%	0.0%
Cash Flow Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Capital Expenditures	37.40	15.00	17.00	16.00	16.90	27.81	45.27	40.88	26.54	10.74	10.99
growth rate		-59.9%	13.3%	-5.9%	5.6%	64.5%	62.8%	-9.7%	-35.1%	-59.5%	2.3%
Cash Dividends	15.00	15.00	17.48	23.33	27.66	27.65	29.49	28.30	25.39	18.38	16.64
growth rate		0.0%	16.5%	33.5%	18.6%	0.0%	6.7%	-4.0%	-10.3%	-27.6%	-9.5%
Cash From OA	62.60	89.00	107.02	96.16	103.16	110.13	104.75	84.25	50.86	68.27	33.32
growth rate		42.2%	20.2%	-10.2%	7.3%	6.8%	-4.9%	-19.6%	-39.6%	34.2%	-51.2%
FCF per Share	0.63	1.15	4.79	2.90	5.43	3.68	2.90	2.69	1.42	3.27	0.78
growth rate		82.5%	316.5%	-39.5%	87.2%	-32.2%	-21.2%	-7.2%	-47.2%	130.3%	-76.2%
Sale Purchase of Stock				0.10	0.10	0.10	0.10
growth rate					0.0%	0.0%	0.0%
FCF	6.00	68.00	82.00	73.00	77.00	75.00	51.00	37.00	13.00	48.00	13.00
growth rate		1,033.3%	20.6%	-11.0%	5.5%	-2.6%	-32.0%	-27.5%	-64.9%	269.2%	-72.9%
Income Statement	Dec '11	Dec '12	Dec '13	Dec '14	Dec '15	Dec '16	Dec '17	Dec '18	Dec '19	Dec '20	Dec '21
Sales	523.20	567.00	617.99	609.98	607.96	614.49	617.54	604.22	557.13	513.58	455.20
growth rate		8.4%	9.0%	-1.3%	-0.3%	1.1%	0.5%	-2.2%	-7.8%	-7.8%	-11.4%
Op.Income	63.70	50.00	146.03	146.11	135.18	133.92	130.01	108.40	83.79	81.86	48.96
growth rate		-21.5%	192.1%	0.1%	-7.5%	-0.9%	-2.9%	-16.6%	-22.7%	-2.3%	-40.2%
IBT	67.50	83.40	131.24	141.32	123.45	126.90	123.13	103.99	64.39	37.22	46.11
growth rate		23.6%	57.4%	7.7%	-12.7%	2.8%	-3.0%	-15.5%	-38.1%	-42.2%	23.9%
Net Income	42.20	50.00	82.40	89.05	73.93	77.73	78.24	57.46	40.63	26.21	28.56
growth rate		18.5%	64.8%	8.1%	-17.0%	5.1%	0.7%	-26.6%	-29.3%	-35.5%	9.0%
EPS	1.97	2.36	4.24	4.62	4.01	4.22	4.25	3.23	2.32	1.50	1.63
growth rate		19.8%	79.7%	9.0%	-13.2%	5.2%	0.7%	-24.0%	-28.2%	-35.3%	8.7%
Gross Profit	404.60	291.00	357.07	354.21	349.46	355.42	358.90	469.57	429.90	394.74	327.62
growth rate		-28.1%	22.7%	-0.8%	-1.3%	1.7%	1.0%	30.8%	-8.5%	-8.2%	-17.0%
R&D	4.60	6.60	6.28	5.40	4.21	3.95	3.59	3.83	3.13	3.52	2.99
growth rate		43.5%	-4.8%	-14.0%	-22.2%	-6.0%	-9.3%	6.7%	-18.1%	12.2%	-15.0%

Quarterly Statements

Item Name	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Earnings BIT	-3.10	27.57	27.57	10.72	10.72
growth rate		100.0%	0.0%	-61.1%	0.0%
Balance Sheet	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Acct.Receivable	91.39	126.31	126.31	100.47	100.47
growth rate		38.2%	0.0%	-20.5%	0.0%
Acct.Payable	30.24	44.18	44.18	44.08	44.08
growth rate		46.1%	0.0%	-0.2%	0.0%
Cur.Assets	401.51	452.36	452.36	447.72	447.72
growth rate		12.7%	0.0%	-1.0%	0.0%
Total Assets	734.23	770.70	770.70	770.63	770.63
growth rate		5.0%	0.0%	0.0%	0.0%
Cash	212.89	234.50	234.50	244.08	244.08
growth rate		10.2%	0.0%	4.1%	0.0%
Inventory	87.03	85.56	85.56	95.82	95.82
growth rate		-1.7%	0.0%	12.0%	0.0%
Cur.Liabilities	155.90	158.24	158.24	154.20	154.20
growth rate		1.5%	0.0%	-2.6%	0.0%
Liabilities	244.75	238.93	238.93	237.91	237.91
growth rate		-2.4%	0.0%	-0.4%	0.0%
LT Debt	2.41	2.35	2.35	15.02	15.02
growth rate		-2.5%	0.0%	540.1%	0.0%
Equity	489.44	531.74	531.74	532.73	532.73
growth rate		8.6%	0.0%	0.2%	0.0%
Common Shares	17.55	17.55	17.55	17.55	17.55
growth rate		0.0%	0.0%	0.0%	0.0%
Cash Flow Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Capital Expenditures	2.57	2.93	2.93	3.03	3.03
growth rate		14.0%	0.0%	3.5%	0.0%
Cash Dividends	8.32	8.25	8.25	8.25	8.25
growth rate		-0.9%	0.0%	0.0%	0.0%
Cash From OA	2.89	13.76	13.76	20.58	20.58
growth rate		375.6%	0.0%	49.5%	0.0%
Sale Purchase of Stock
growth rate
FCF	0.33	10.84	10.84	17.55	17.55
growth rate		3,214.2%	0.0%	61.9%	0.0%
Income Statement	Jun '21	Sep '21	Dec '21	Mar '22	Jun '22
Sales	94.97	132.64	132.64	128.38	128.38
growth rate		39.7%	0.0%	-3.2%	0.0%
Op.Income	-3.10	27.57	27.57	10.72	10.72
growth rate		100.0%	0.0%	-61.1%	0.0%
IBT	-5.87	28.92	28.92	8.55	8.55
growth rate		100.0%	0.0%	-70.4%	0.0%
Net Income	-4.76	19.04	19.04	6.26	6.26
growth rate		100.0%	0.0%	-67.1%	0.0%
Gross Profit	44.37	96.68	96.68	86.20	86.20
growth rate		117.9%	0.0%	-10.8%	0.0%
R&D	0.65	0.85	0.85	1.36	1.36
growth rate		30.4%	0.0%	60.8%	0.0%

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

F (0.00)

YOY Growth Grade:

F (13.62)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Dividend Yield: 2.1%
Beta: 0.55
Beta of 0.5541 suggests that the asset is less volatile than the rest of the market.
PE: 0.84
EY: 119.8%
PEG: 0.05
PEG Ratio of 0.05 suggests that stock is underpriced.
PEGY: 0.05
PEGY Ratio of 0.05 suggests that stock is underpriced.
Price/BVPS: 0.06
Price to BVPS Ratio of 0.06 suggests that stock is undervalued.

Profitability Ratios

ROE: 5.5%
Return on Equity (ROE) of 5.5% suggests that a company may not be able to fund future growth from within.
ROS: 10.8%
The value of Return on Sales depends on the business and/or industry. Usually the higher ratio the better.
ROA: 6.0%
Return on Assets (ROA). Low ratio usually means poor performance, or ineffective use of assets by management. High ratio usually means good performance.
ROI: 8.7%
Return on Investment (ROI) of 8.7% suggests that management is inefficient or it could reflect a highly capitalized, conservatively operated business with little long term debt.
ROIC: 21.5%
Return on Invested Capital (ROIC) of 21.5% suggests that a company is doing well.

Liquidity Ratios

Current Ratio: 2.86
Current Ratio of 2.86 suggests that money that could be working for the business is tied up in government securities, cash savings or other safe funds.
Quick Ratio: 2.28
Quick Ratio of 2.28 suggests that a company is doing well.
Cash Turnover: 1.55
Turnover Of Cash Ratio of 1.55 suggests that a company may have funds tied up in short-term low-yielding assets or may have a cash surplus, which is not invested in the business.
Equity Ratio: 69.0%
Equity Ratio of 69.0% suggests that a large percent of the company's assets financed by shareholder equity, which is good.
Debt/Equity: 44.9%
Debt to Equity Ratio of 44.9% suggests that a company is doing well.
Debt/FCF: 1.16
Debt/FCF of 1.16 suggests that a company is doing well and can pay off its long term debt within three years.

Efficiency Ratios

Avg Collection Period: 101.28
Average Collection Period of 101.28 days suggests a slow turnover, which may be the result of a number of bad accounts, or a tax collection policy or perhaps credit is being used to generate sales.
Inventory Turnover: 1.49
Inventory Turnover Ratio of 1.49 suggests a large inventory, a never-out-of-stock situation, perhaps some obsolete items, or it could indicate poor liquidity and possible overstocking of items.
Cash Flow Ratio: 4.80
Cash Flow Ratio of 4.80 suggests a company is doing OK, but lower inventory is generally viewed as a positive trend.
Profit Margin: 6.3%

Value Price

PE and EPS

	Historical	Current	Forward
PE	29.99	1.03	16.47
EPS / Growth	247.5%	1.50	16.3%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 3.7%

Estimates	Pessimistic	Moderate	Optimistic
Rate of Return	15.0%
MOS Price %	50 %
Future EPS Growth	3.7%	10.0%	10.0%
Future PE	7.32	22.14	22.14
Future EPS	2.14	3.88	3.88
Value Price MOS %	3.88 152.0%	21.21 1,277.3%	21.21 1,277.3%
MOS Price	1.94	10.61	10.61
IRT	0.99	0.94	0.94

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Graham Number: 30.68
Graham MOS: 1,892.0%

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.